Thioguanine and low dose thiopurines and allopurinol are both safe options after failure of conventional thiopurines: a comparative analysis of two multicentre cohorts

Vince B. C. Biemans; E. Savelkoul; G. Dijkstra; M.  Simsek; Ruben Y. Gabriels; M. Pierik; R. West; N. de Boer; Frank Hoentjen

Thioguanine and low dose thiopurines and allopurinol are both safe options after failure of conventional thiopurines: a comparative analysis of two multicentre cohorts

Vince B. C. Biemans, E. Savelkoul, G. Dijkstra, M. Simsek, Ruben Y. Gabriels, M. Pierik, R. West, N. de Boer, Frank Hoentjen

Research output: Contribution to conference › Abstract › Academic

Original language	English
Pages	S404-S405
Number of pages	2
Publication status	Published - 15-Jan-2020

Handle.net

Persistent link

Cite this

@conference{bc5c62fc055a42fba72fb9359f6b6327,

title = "Thioguanine and low dose thiopurines and allopurinol are both safe options after failure of conventional thiopurines: a comparative analysis of two multicentre cohorts",

author = "Biemans, {Vince B. C.} and E. Savelkoul and G. Dijkstra and M. Simsek and Gabriels, {Ruben Y.} and M. Pierik and R. West and {de Boer}, N. and Frank Hoentjen",

year = "2020",

month = jan,

day = "15",

language = "English",

pages = "S404--S405",

}

TY - CONF

T1 - Thioguanine and low dose thiopurines and allopurinol are both safe options after failure of conventional thiopurines

T2 - a comparative analysis of two multicentre cohorts

AU - Biemans, Vince B. C.

AU - Savelkoul, E.

AU - Dijkstra, G.

AU - Simsek, M.

AU - Gabriels, Ruben Y.

AU - Pierik, M.

AU - West, R.

AU - de Boer, N.

AU - Hoentjen, Frank

PY - 2020/1/15

Y1 - 2020/1/15

M3 - Abstract

SP - S404-S405

ER -